Stay updated with breaking news from Monitor Deloitte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company's Board as independent members Regulatory
Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company’s Board as independent membersPARIS--(BUSINESS WIRE)--Regulatory News:Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxe...
El año 2021 se va a convertir en el más caro de la historia del recibo de la luz en España. Los máximos históricos se suceden uno tras otro, el último el pasado
Can the pharma industry to build long-term trust with consumers post-pandemic? (Getty Images) Despite the pandemic and the promise of a relationship reset, half of Americans still don’t trust pharma companies. That’s according to Deloitte focus group studies in the U.S., India, South Africa and the U.K. While 80% of those surveyed in the other three countries said they trusted or were neutral toward pharma, Americans remain skeptical. It’s not all bad news, though. Deloitte found that the pandemic has moved the needle somewhat—and in broader reputation polls even more. Plus, there is...
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA ("EEA") (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE SECURITIES MAY BE LAWFULLY MARKETED) OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION. PLEASE SEE ...